KLR Investment Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,292
Closed -$324K 209
2023
Q3
$324K Sell
8,292
-508
-6% -$10.6K 0.29% 111
2023
Q2
$286K Buy
8,800
+31
+0.4% +$1.13K 0.24% 145
2023
Q1
$343K Sell
8,769
-2,536
-22% -$124K 0.3% 110
2022
Q4
$597K Buy
+11,305
New +$551K 0.49% 51

Other funds holding SILK

KLR Investment Advisors's SILK Position: Q4 2023 in Review

KLR Investment Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 8,292 shares — an estimated $324K sold.

KLR Investment Advisors first reported a position in SILK in Q4 2022 and held it in 4 quarters. The position peaked at $597K in Q4 2022. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • KLR Investment Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • KLR Investment Advisors sold 8,292 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $324K.
  • KLR Investment Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
  • KLR Investment Advisors's Silk Road Medical, Inc. Common Stock position peaked at $597K in Q4 2022.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on KLR Investment Advisors's 13F filing for Q4 2023, filed 8 Feb 2024.